White label – Pompe disease - ClinicalTrials.eu

Study of OSE2101 vaccine alone or with pembrolizumab as maintenance therapy for patients with platinum-sensitive recurrent ovarian cancer after chemotherapy

Not recruiting

2 1 1 1
Investigated Drugs:
Study on Dalbavancin and Rifampicin for Treating Prosthetic Joint Infections in Patients with Hip, Knee, and Shoulder Replacements

Not recruiting

2 1 1 1
Investigated Drugs:
- Dalbavancin
- Rifampicin
Study of Durvalumab and Tremelimumab for Patients with Colorectal and Endometrial Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Endometrial cancer metastatic
- Colorectal cancer metastatic
Investigated Drugs:
- Tremelimumab
- Durvalumab
Study on Irinotecan for Brain Metastases in Patients with HER2-Negative Breast Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- HER2 negative breast cancer
Investigated Drugs:
- Irinotecan
Study on Cabozantinib, Nivolumab, and Ipilimumab for Patients with Advanced or Metastatic Kidney Cancer Who Have Not Received Prior Treatment

Not recruiting

3 1 1
Investigated Drugs:
+3
Study on Efgartigimod for Patients with Antibody-Mediated Rejection after Kidney Transplant

Not recruiting

2 1
Investigated Drugs:
- Efgartigimod Alfa
Study on the Effects of Mycophenolate Mofetil and Prednisolone in Patients with Chronic Virus-Negative Inflammatory Cardiomyopathy

Not recruiting

4 1 1
Investigated Diseases:
- Cardiomyopathy
Investigated Drugs:
- Mycophenolate Mofetil
- Prednisolone
Study on Faricimab for Patients with Neovascular Age-Related Macular Degeneration Who Have Not Received Prior Treatment

Not recruiting

3 1 1 1
Investigated Diseases:
- Age-related macular degeneration
Investigated Drugs:
- Faricimab
Study on Azithromycin for Treating Chronic Sinusitis in Adults

Not recruiting

3 1 1
Investigated Diseases:
- Chronic sinusitis
- Sinusitis bacterial
Investigated Drugs:
- Azithromycin
Study on the Effects of Epinephrine, Norepinephrine, and Phenylephrine on Heart Function During Major Abdominal Surgery

Not recruiting

3 1 1 1
Investigated Drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies